We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Techniques Yield Data on How HIV Infects Cells and Offer Insights into Vaccine Design

By LabMedica International staff writers
Posted on 12 Sep 2008
The use of sophisticated imaging techniques has allowed researchers to visualize how a key part of the human immunodeficiency virus (HIV) changes shape after binding to immune system cells or to infection-fighting antibodies. More...
Although scientists had been able to visualize individual components of this part of the virus, called the HIV spike, the new study characterizes, for the first time, the structure of the intact spike on virus particles, which is a critical piece of information that may help in the design of new vaccines or drugs to combat HIV infection.

The research was conducted by scientists at the U.S. National Cancer Institute (NCI; Bethesda, MD, USA), part of the National Institutes of Health. The results were published online July 30, 2008, in the journal Nature. "Understanding the structure and design of the HIV spike has been the subject of intensive effort for over a decade because of its potential importance in understanding mechanisms of viral entry into immune system cells and designing treatment and prevention approaches,” said NCI director John E. Niederhuber, M.D. "The sophisticated imaging techniques used in this HIV/AIDS study have the potential to advance our understanding of not only HIV, but many other diseases, including cancer.”

"Previous research showing how HIV interacts with immune system cells and antibodies has been important in vaccine design,” said Sriram Subramaniam, Ph.D., from NCI's Center for Cancer Research, and head of the research team that performed the study. "However, understanding the complete structure of the viral spike may reveal other vulnerable targets. This knowledge will be crucial to solving the puzzles associated with strategies at the heart of virus invasion.”

The HIV virus binds to and infects target cells through the interaction of viral spikes and receptors on the surface of the cells. The spike is comprised of two types of proteins, called gp120 and gp41, which interact with one another to form a protein pair. The final structure of the spike is achieved by the interaction of three of these protein pairs on the surface of the virus, forming a structure called a trimer. The head of the spike consists of gp120, and it is responsible for binding to the receptor on the target cell, which is a protein called CD4; gp41 covers the virus' outer membrane, forming the stalk of the spike. gp41 is responsible for events in which HIV injects its genetic material into the host cells. The trimeric spike is held together by strong contacts among the gp41 proteins at the bottom but by only a few contacts among the gp120 proteins at the top.

The researchers utilized imaging techniques, including cryo-electron tomography, to produce three-dimensional renderings (3D) of the spike. Essentially, the researchers froze the virus and took images of it from different angles. Then, they used advanced computer image-processing methods to average thousands of high-resolution images of individual spikes, which enabled them to interpret the 3D images in terms of atomic structures. The researchers discovered that upon interaction with CD4 receptors, the gp120 proteins rearrange, causing the spike to spring open, exposing the gp41 stalk and other structures that are required for the virus to infect target cells. This rearrangement also pushes the virus and the target cell closer together, which may help gp41 penetrate the target cell, allowing the virus' genetic material to be injected.

Although most of the antibodies that the body produces to fight HIV are ineffective, some antibodies are produced that can neutralize HIV. To gain a better determine of how these antibodies work, the researchers visualized the HIV spike bound to an antibody called b12 that can neutralize a broad range of HIV particles. The researchers demonstrated that, in response to b12, the gp120 proteins rearrange in a similar way as with CD4, but b12 prevents the spike from opening completely. The antibody locks the spike in a semi-open position, preventing the series of actions that enable HIV to infect the target cell.

"The insights gained by understanding the binding of one of the most effective broadly neutralizing antibodies lays the foundation for designing more effective strategies for blocking HIV infection,” said Dr. Subramaniam. "We are working actively to increase the resolution of our structural analyses, and to understand the differences in binding between antibodies that neutralize, which are very rare in HIV-infected individuals, and non-neutralizing antibodies that are found in almost all AIDS patients. Knowing what these differences are will be critical to designing better strategies to neutralize HIV and to providing a new addition to the arsenal of strategies to combat HIV/AIDS.”

The Subramaniam lab has been pioneering developments in electron tomography and related methods for 3D electron microscopy, and is applying these emerging technologies to understanding not only virus-host interactions but also structures inside the cell that differentiate cancer cells from healthy cells.

Related Links:

National Cancer Institute


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Portable Electronic Pipette
Mini 96
Gel Cards
DG Gel Cards
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.